139
Participants
Start Date
June 5, 2020
Primary Completion Date
July 19, 2023
Study Completion Date
July 19, 2023
Placebo
Participants will receive oral placebo matched to RG7774
RG7774
Participants will receive oral RG7774
Sydney Eye Hospital, Sydney
Sydney Retina Clinic and Day Surgery, Sydney
Centre For Eye Research Australia, East Melbourne
Retina Specialists Victoria, Rowville
Clinica Barraquer, Barcelona
Hospital Universitari de Bellvitge; Servicio de Oftalmologia, L'Hospitalet de Llobregat
Ophthalmic Consultants of Long Island, Oceanside
Velocity Clinical Research, East Syracuse
Erie Retinal Surgery, Erie
Cumberland Valley Retina PC, Hagerstown
Charlotte Eye Ear Nose and Throat Associates, Charlotte
Hospital Universitario Puerta de Hierro, Majadahonda
Charleston Neuroscience Institute, Ladson
Marietta Eye Clinic, Marietta
Southeast Retina Center, Augusta
Retina Specialty Institute, Pensacola
Florida Eye Associates, Melbourne
Rand Eye, Deerfield Beach
Medeye Associates, Miami
Retina Vitreous Assoc of FL, St. Petersburg
Florida Retina Consultants, Lakeland
Southeastern Retina Associates Chattanooga, Chattanooga
Charles Retina Institute, Germantown
Deep Blue Retina PLLC, Southaven
Pio del Rio Hortega University Hospital, Valladolid
University of Michigan, Kellogg Eye Center, Ann Arbor
Miguel Servet University Hospital, Zaragoza
Retina Associated Ltd, Elmhurst
University Retina and Macula Associates, PC, Oak Forest
Strategic Clinical Research Group, LLC, Willow Park
Retinal Consultants of Houston, The Woodlands
San Antonio Eye Center, San Antonio
Austin Clinical Research LLC, Austin
Retina Res Institute of Texas, Abilene
Retina Consultants of Southern Colorado PC, Colorado Springs
Arizona Retina and Vitreous Consultants, Phoenix
Retina Associates Tucson, Tucson
Eye Associates of New Mexico, Albuquerque
Sierra Eye Associates, Reno
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
Win Retina, Arcadia
Global Research Management, Glendale
EyeHealth Northwest, Portland
Retina Group of New England, Waterford
Envision Ocular, LLC, Bloomfield
Retina Consultants of Texas, The Woodlands
Centrum Medyczne Julianow; Zeglarska, ?ód?
Gabinet Okulistyczny Prof Edward Wylegala, Katowice
Centrum Medyczne UNO-MED, Krakow
Centrum Diagnostyki i Mikrochirurgii Oka LENS, Olsztyn
LensClinic, Rybnik
Emanuelli Research and Development Center LLC, Arecibo
Fakultna nemocnica s poliklinikou F.D. Roosevelta, Banská Bystrica
Klinika Oftalmológie LFUK a UNB, Bratislava
O?ná klinika UNB a SZU, Bratislava
3F s.r.o, Košice
Fakultna nemocnica Trencin, Trenčín
Fakultna nemocnica s poliklinikou Zilina; Ocne oddelenie, Žilina
Hospital General de Catalunya, San Cugat Del Valles
Hospital Dos de Maig, Barcelona
Hospital Clinic I Provincial, Barcelona
Royal Victoria Hospital; Outpatients Department, Belfast
Colchester General Hospital, Colchester, Essex
Royal Surrey County Hospital; Eye Clinic Research office, Guildford
Hull University Teaching Hospitals NHS Trust, Hull
Royal Liverpool University Hospital, Liverpool
Nottingham University Hospitals NHS Trust, Nottingham
Sunderland Eye Infirmary, Sunderland
Hoffmann-La Roche
INDUSTRY